Orphan Drug Status

Related by string. Orphan Drug status * orphaned . Orphans . Orphaned . orphans : Little Orphan Annie . widows orphans . Orphan Drug Designation . Swedish Orphan Biovitrum / Drugs . DRUG . drugs : Drug Task Force . Prescription Drug User Fee . Drug Enforcement Administration / STATUS . status . statu : Scheduled Tribe status . acquisition Status Agreed . Approved Destination Status * *

Related by context. Frequent words. (Click for all words.) 81 Fast Track Designation 78 Orphan Drug status 77 Orphan Drug designation 73 Orphan Drug Designation 73 orphan designation 71 Orphan Medicinal Product 70 Phase III Clinical Trial 69 Marketing Authorization Application 69 Marketing Authorization 69 Pivotal Phase III 68 Phase III Trial 68 Drug Candidate 67 orphan medicinal product 67 Fast Track designation 67 Priority Review 66 Pivotal Trial 66 Icatibant 66 FDA Clearance 66 Orphan Drug 65 Torisel 65 Genasense R 65 Mutual Recognition Procedure 64 ATryn ® 64 Marketing Authorization Application MAA 64 Amrubicin 64 Irinotecan 64 Pixantrone 64 Lenalidomide 64 Investigational Device Exemption 64 Pirfenidone 63 Nimotuzumab 63 Nexavar ® 63 TORISEL 63 PROMACTA 63 Pivotal Phase 63 Everolimus 63 Alemtuzumab 63 FDA Approval 62 FIRAZYR 62 REVLIMID R 62 TYKERB 62 ELAPRASE 62 Regulatory Approval 62 Loramyc ® 62 methylnaltrexone 62 ATryn R 62 Monoclonal Antibody 62 Completes Enrollment 62 Clinical Trial Results 62 Combination Therapy 61 k Clearance 61 Complete Response 61 NOXAFIL 61 Ofatumumab 61 FDA Clears 61 alvimopan 61 Biologics License Application 61 Exclusive License 61 Gaucher Disease 61 eltrombopag 61 REVLIMID ® 61 Bevacizumab 61 Allovectin 7 R 60 silodosin 60 Jevtana 60 Monotherapy 60 pancreatic insufficiency 60 Avastin bevacizumab 60 orphan drug 60 European Medicines Evaluation 60 Cancer Vaccine 60 Patients Treated 60 MOZOBIL 60 Onsolis 60 Belinostat 60 Laquinimod 60 Perifosine 59 Satraplatin 59 Naglazyme 59 Diamyd ® 59 Maraviroc 59 Taxotere ® 59 Rhucin ® 59 ROTATEQ 59 Vasovist 59 supplemental Biologics License Application 59 Rifaximin 59 Erlotinib 59 REPLAGAL 59 Initiates Phase 59 Advexin 59 Santhera 59 Voreloxin 59 granted orphan 59 ADVEXIN 59 Azedra 59 BLA submission 59 CE Marking 59 Chronic Hepatitis C 59 Azixa 59 SUTENT

Back to home page